In conclusion, the increased expression of FBXL18 in HCC patients promoted hepatocarcinogenesis through the induction of RPS15A ubiquitination and upregulation of SMAD3 expression (Fig. 6F). This evidence concerns the gene SMAD3 and hepatocellular carcinoma.